A Study to Assess the Efficacy and Safety of Daily OM-85 in Young Children With Recurrent Wheezing
Status:
Not yet recruiting
Trial end date:
2025-02-28
Target enrollment:
Participant gender:
Summary
This study will assess the efficacy and safety of daily OM-85 treatment compared to placebo
in children aged 6 months to 5 years with recurrent wheezing